Yadagiri, Mahender, Sandwell and West Birmingham Hospitals NHS Trust, United Kingdom

• British Journal of Diabetes Vol. 22 No. 2 (2022): December 2022 - Original Research
  Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Original Research
  The effect of dapagliflozin on alanine aminotransferase as a marker of liver inflammation: updated results from the ABCD dapagliflozin audit
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Original Research
  Effects of canagliflozin are mostly observed at first follow-up, within 6 months of commencement: results for the ABCD canagliflozin audit
  Abstract  PDF  HTML